- Product Details
Keywords
- Almitrine bismesylate
- Almitrine bismesylate Nanyang Tianhua Pharm
- Almitrine bismesylate Nanyang Tianhua Pharm
Quick Details
- ProName: Almitrine bismesylate
- CasNo: 29608-49-9
- Molecular Formula: C26H29F2N7.2(CH4O3S)
- Appearance: white or white crystalline powder
- Application: Mainly used for sub-acute and chronic ...
- PackAge: TIN/Carton
- Port: Anyport in China
- ProductionCapacity: Metric Ton/Day
- Purity: 99.4%
- Storage: PRESERVED IN AN AIRTIGHT CONTAINER AND...
- Transportation: By Air/by sea
- LimitNum: 20 Kilogram
Superiority
Almitrine Bismesylate
CAS NO.: 29608-49-9
white or white crystalline powder
Standard: CP2010
Acting on the carotid body chemoreceptors, excited breathing,
thereby strengthening the gas exchange between alveolar and capillary,
Increased arterial oxygen pressure and oxygen saturatio,so that make the brain function improved and strengthened.
Mainly used for sub-acute and chronic cerebrovascular insufficiency,
sequelae of cerebral sudden stroke, mild to moderate senile dementia and memory disorders of elders
and ischemic cochlear vestibular function disorder.
Mainly used for sub-acute and chronic cerebrovascular insufficiency,
sequelae of cerebral sudden stroke,
mild to moderate senile dementia and memory disorders of elders and ischemic cochlear vestibular function disorder.
Details
Almitrine Bismesylate
CAS NO.: 29608-49-9
white or white crystalline powder
Standard: CP2010
Acting on the carotid body chemoreceptors, excited breathing,
thereby strengthening the gas exchange between alveolar and capillary,
Increased arterial oxygen pressure and oxygen saturatio,so that make the brain function improved and strengthened.
Mainly used for sub-acute and chronic cerebrovascular insufficiency,
sequelae of cerebral sudden stroke,
mild to moderate senile dementia and memory disorders of elders and ischemic cochlear vestibular function disorder.
Mainly used for sub-acute and chronic cerebrovascular insufficiency,
sequelae of cerebral sudden stroke,
mild to moderate senile dementia and memory disorders of elders and ischemic cochlear vestibular function disorder.